Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy
Article in Nefrología (English Edition) (November 2021)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process
Article in Drugs in R&D (September 2021)
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy
Article in Nefrología (English Edition) (March 2021)